Clinical Trial Update: Replexa+ Shortwave Diathermy Device for Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy [NA]

View source ↗

Summary

Recruitment is ongoing for a study evaluating the Replexa+ Shortwave Diathermy Device in Peripheral Arterial Disease and Peripheral Neuropathy. Sponsor is India…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease
• Peripheral Neuropathy

Drugs mentioned

• Replexa+ Shortwave Diathermy Device

Snippet

Sponsor: Indiana University | Conditions: Peripheral Arterial Disease, Peripheral Neuropathy | NA | Status: RECRUITING